The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
Open accessAbstract
As an essential innate immune population for maintaining body homeostasis and warding off foreign pathogens, macrophages display high plasticity and perform diverse supportive functions specialized to different tissue compartments. Consequently, aberrance in macrophage functions contributes substantially to progression of several diseases including cancer, fibrosis, and diabetes. In the context of cancer, tumor-associated macrophages (TAMs) in tumor microenvironment (TME) typically promote cancer cell proliferation, immunosuppression, and angiogenesis in support of tumor growth and metastasis. Oftentimes, the abundance of TAMs in tumor is correlated with poor disease prognosis. Hence, significant attention has been drawn towards development of cancer immunotherapies targeting these TAMs; either depleting them from tumor, blocking their pro-tumoral functions, or restoring their immunostimulatory/tumoricidal properties. This review aims to introduce readers to various aspects in development and evaluation of TAM-targeted therapeutics in pre-clinical and clinical stages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · cited 1×
“While the natural tendency of M2 macrophages to more readily internalize nanoparticles could be beneficial for designing TAM-targeted therapy, the resident macrophages’ penchant for internalizing nanoparticles is still an important challenge in developing TAM-targeted therapies [185][186][181][187].”
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Schulz, C., Perdiguero, E. G., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E. W., Pollard, J. W., et al. (2012) · Science · doi:10.1126/science.1219179 · Cited by 2,578
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Takeda, K., & Akira, S. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.10.003 · Cited by 2,461
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., & Amit, I. (2014) · Cell · doi:10.1016/j.cell.2014.11.018 · Cited by 2,167
Davies, L. C., Jenkins, S. J., Allen, J. E., & Taylor, P. R. (2013) · Nature Immunology · doi:10.1038/ni.2705 · Cited by 2,096
Role of target geometry in phagocytosis
Champion, J. A., & Mitragotri, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600997103 · Cited by 2,074
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
Italiani, P., & Boraschi, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00514 · Cited by 2,067
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000
Monocytes and macrophages: developmental pathways and tissue homeostasis
Ginhoux, F., & Jung, S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3671 · Cited by 1,840
Rooijen, N. V., & Sanders, A. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90012-4 · Cited by 1,779
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., et al. (2011) · Science · doi:10.1126/science.1198443 · Cited by 1,672
Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,666
Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J. S., Nejadnik, H., Goodman, S., Moseley, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.168 · Cited by 1,647
Bisphosphonates: Mechanism of action and role in clinical practice
Drake, M. T., Clarke, B. L., & Khosla, S. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.9.1032 · Cited by 1,644
Proceedings of the 8th Workshop on Programming Languages and Operating Systems
(2015) · doi:10.1145/2818302 · Cited by 1,628
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Iron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621
Essential role of Stat6 in IL-4 signalling
Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S.-I., Nakanishi, K., Yoshida, N., Kishimoto, T., & Akira, S. (1996) · Nature · doi:10.1038/380627a0 · Cited by 1,557 · cited 1×
“Instead, macrophages respond to cytokines IL-4 and IL-13 released by damaged cells resulting in activation of the STAT6 transcription factor through the Janus kinase – signal transducers and activators of transcription (JAK-STAT) pathway, effectively turning on signature anti-inflammatory genes like arginase (Arg1) an…”
Lipid metabolic reprogramming in cancer cells
Beloribi-Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,398
The cellular and molecular origin of tumor-associated macrophages
Franklin, R. A., Liao, W., Sarkar, A., Kim, M. V., Bivona, M. R., Liu, K., Pamer, E. G., & Li, M. O. (2014) · Science · doi:10.1126/science.1252510 · Cited by 1,393
Alveolar macrophages: plasticity in a tissue-specific context
Hussell, T., & Bell, T. J. (2014) · Nature Reviews Immunology · doi:10.1038/nri3600 · Cited by 1,377
PI3Kγ is a molecular switch that controls immune suppression
Kaneda, M. M., Messer, K. S., Ralainirina, N., Li, H., Leem, C. J., Gorjestani, S., Woo, G., Nguyen, A. V., Figueiredo, C. C., Foubert, P., et al. (2016) · Nature · doi:10.1038/nature19834 · Cited by 1,173
Microglia development and function
Nayak, D., Roth, T. L., & McGavern, D. B. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120240 · Cited by 1,154
Chao, M. P., Alizadeh, A. A., Tang, C., Myklebust, J. H., Varghese, B., Gill, S., Jan, M., Cha, A. C., Chan, C. K., Tan, B. T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.044 · Cited by 1,087
Macrophage Regulation of Tumor Responses to Anticancer Therapies
De Palma, M., & Lewis, C. E. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.013 · Cited by 1,079
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M., & Rossi, F. M. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2887 · Cited by 1,061
Langerhans cells renew in the skin throughout life under steady-state conditions
Merad, M., Manz, M. G., Karsunky, H., Wagers, A., Peters, W., Charo, I., Weissman, I. L., Cyster, J. G., & Engleman, E. G. (2002) · Nature Immunology · doi:10.1038/ni852 · Cited by 977
Specification of tissue-resident macrophages during organogenesis
Mass, E., Ballesteros, I., Farlik, M., Halbritter, F., Günther, P., Crozet, L., Jacome-Galarza, C. E., Händler, K., Klughammer, J., Kobayashi, Y., et al. (2016) · Science · doi:10.1126/science.aaf4238 · Cited by 891
Okabe, Y., & Medzhitov, R. (2014) · Cell · doi:10.1016/j.cell.2014.04.016 · Cited by 884
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Germano, G., Frapolli, R., Belgiovine, C., Anselmo, A., Pesce, S., Liguori, M., Erba, E., Uboldi, S., Zucchetti, M., Pasqualini, F., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.008 · Cited by 864
Differential macrophage programming in the tumor microenvironment
Ruffell, B., Affara, N. I., & Coussens, L. M. (2012) · Trends in Immunology · doi:10.1016/j.it.2011.12.001 · Cited by 860
Scavenger receptors in homeostasis and immunity
Canton, J., Neculai, D., & Grinstein, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3515 · Cited by 838
Regulation of innate immune cell function by mTOR
Weichhart, T., Hengstschläger, M., & Linke, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3901 · Cited by 830
Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome
Lin, H., Lee, E., Hestir, K., Leo, C., Huang, M., Bosch, E., Halenbeck, R., Wu, G., Zhou, A., Behrens, D., et al. (2008) · Science · doi:10.1126/science.1154370 · Cited by 817
“Re-educating” tumor-associated macrophages by targeting NF-κB
Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080108 · Cited by 792
The role of myeloid cells in cancer therapies
Engblom, C., Pfirschke, C., & Pittet, M. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.54 · Cited by 788
Zhou, D., Huang, C., Lin, Z., Zhan, S., Kong, L., Fang, C., & Li, J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.004 · Cited by 778
Hume, D. A., & MacDonald, K. P. A. (2012) · Blood · doi:10.1182/blood-2011-09-379214 · Cited by 763
Van Dyken, S. J., & Locksley, R. M. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095906 · Cited by 714
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
Choi, C. H. J., Alabi, C. A., Webster, P., & Davis, M. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914140107 · Cited by 699
Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods
Qiu, Y., Liu, Y., Wang, L., Xu, L., Bai, R., Ji, Y., Wu, X., Zhao, Y., Li, Y., & Chen, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.051 · Cited by 689
Macrophages and cancer: from mechanisms to therapeutic implications
Ostuni, R., Kratochvill, F., Murray, P. J., & Natoli, G. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.004 · Cited by 683
Regulation of macrophage development and function in peripheral tissues
Lavin, Y., Mortha, A., Rahman, A., & Merad, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3920 · Cited by 680
The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
Quail, D. F., Bowman, R. L., Akkari, L., Quick, M. L., Schuhmacher, A. J., Huse, J. T., Holland, E. C., Sutton, J. C., & Joyce, J. A. (2016) · Science · doi:10.1126/science.aad3018 · Cited by 666
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
Bonapace, L., Coissieux, M.-M., Wyckoff, J., Mertz, K. D., Varga, Z., Junt, T., & Bentires-Alj, M. (2014) · Nature · doi:10.1038/nature13862 · Cited by 665
The mononuclear phagocyte system
Hume, D. A. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.008 · Cited by 649
Mazzieri, R., Pucci, F., Moi, D., Zonari, E., Ranghetti, A., Berti, A., Politi, L. S., Gentner, B., Brown, J. L., Naldini, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.005 · Cited by 639
Zeisberger, S. M., Odermatt, B., Marty, C., Zehnder-Fjällman, A. H. M., Ballmer-Hofer, K., & Schwendener, R. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603240 · Cited by 623
The interaction of anticancer therapies with tumor-associated macrophages
Mantovani, A., & Allavena, P. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150295 · Cited by 616
Sanford, D. E., Belt, B. A., Panni, R. Z., Mayer, A., Deshpande, A. D., Carpenter, D., Mitchem, J. B., Plambeck-Suess, S. M., Worley, L. A., Goetz, B. D., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0525 · Cited by 613
Georgoudaki, A.-M., Prokopec, K. E., Boura, V. F., Hellqvist, E., Sohn, S., Östling, J., Dahan, R., Harris, R. A., Rantalainen, M., Klevebring, D., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.084 · Cited by 609
Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization
Arranz, A., Doxaki, C., Vergadi, E., Martinez de la Torre, Y., Vaporidi, K., Lagoudaki, E. D., Ieronymaki, E., Androulidaki, A., Venihaki, M., Margioris, A. N., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119038109 · Cited by 608
Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Park, S.-H., Tan, W., Hong, S. H., Shin, M. G., Chung, I.-J., Hong, Y., Bom, H.-S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aak9537 · Cited by 588
Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor
Tap, W. D., Wainberg, Z. A., Anthony, S. P., Ibrahim, P. N., Zhang, C., Healey, J. H., Chmielowski, B., Staddon, A. P., Cohn, A. L., Shapiro, G. I., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411366 · Cited by 582
Molecular Mechanisms of Action of Bisphosphonates: Current Status
Roelofs, A. J., Thompson, K., Gordon, S., & Rogers, M. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0843 · Cited by 568
Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage
Tabata, Y., & Ikada, Y. (1988) · Biomaterials · doi:10.1016/0142-9612(88)90033-6 · Cited by 538
Maira, S.-M., Pecchi, S., Huang, A., Burger, M., Knapp, M., Sterker, D., Schnell, C., Guthy, D., Nagel, T., Wiesmann, M., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0474 · Cited by 529
Moynihan, K. D., Opel, C. F., Szeto, G. L., Tzeng, A., Zhu, E. F., Engreitz, J. M., Williams, R. T., Rakhra, K., Zhang, M. H., Rothschilds, A. M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4200 · Cited by 524
Gpr132 sensing of lactate mediates tumor–macrophage interplay to promote breast cancer metastasis
Chen, P., Zuo, H., Xiong, H., Kolar, M. J., Chu, Q., Saghatelian, A., Siegwart, D. J., & Wan, Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614035114 · Cited by 520
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Hughes, R., Qian, B.-Z., Rowan, C., Muthana, M., Keklikoglou, I., Olson, O. C., Tazzyman, S., Danson, S., Addison, C., Clemons, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3587 · Cited by 518
MacDonald, K. P. A., Palmer, J. S., Cronau, S., Seppanen, E., Olver, S., Raffelt, N. C., Kuns, R., Pettit, A. R., Clouston, A., Wainwright, B., et al. (2010) · Blood · doi:10.1182/blood-2010-02-266296 · Cited by 506
Targeting the CCL2-CCR2 signaling axis in cancer metastasis
Lim, S. Y., Yuzhalin, A. E., Gordon-Weeks, A. N., & Muschel, R. J. (2016) · Oncotarget · doi:10.18632/oncotarget.7376 · Cited by 501
Kodumudi, K. N., Woan, K., Gilvary, D. L., Sahakian, E., Wei, S., & Djeu, J. Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0733 · Cited by 500
Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
Weiskopf, K., Ring, A. M., Ho, C. C. M., Volkmer, J.-P., Levin, A. M., Volkmer, A. K., Özkan, E., Fernhoff, N. B., van de Rijn, M., Weissman, I. L., et al. (2013) · Science · doi:10.1126/science.1238856 · Cited by 495
Prima, V., Kaliberova, L. N., Kaliberov, S., Curiel, D. T., & Kusmartsev, S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612920114 · Cited by 494
Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis
Kohyama, M., Ise, W., Edelson, B. T., Wilker, P. R., Hildner, K., Mejia, C., Frazier, W. A., Murphy, T. L., & Murphy, K. M. (2009) · Nature · doi:10.1038/nature07472 · Cited by 479 · cited 1×
“Splenic red pulp macrophages are responsible for the recycling process of red blood cells [11][12][13].”
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
Rodrik-Outmezguine, V. S., Okaniwa, M., Yao, Z., Novotny, C. J., McWhirter, C., Banaji, A., Won, H., Wong, W., Berger, M., de Stanchina, E., et al. (2016) · Nature · doi:10.1038/nature17963 · Cited by 479
Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
Liu, J., Wang, L., Zhao, F., Tseng, S., Narayanan, C., Shura, L., Willingham, S., Howard, M., Prohaska, S., Volkmer, J., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137345 · Cited by 475
Identification of the receptor scavenging hemopexin-heme complexes
Hvidberg, V., Maniecki, M. B., Jacobsen, C., Højrup, P., Møller, H. J., & Moestrup, S. K. (2005) · Blood · doi:10.1182/blood-2005-03-1185 · Cited by 473
Metabolism of stromal and immune cells in health and disease
Ghesquière, B., Wong, B. W., Kuchnio, A., & Carmeliet, P. (2014) · Nature · doi:10.1038/nature13312 · Cited by 451
STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion
Kusmartsev, S., & Gabrilovich, D. I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4880 · Cited by 445
Tumour‐associated macrophages act as a slow‐release reservoir of nano‐therapeutic Pt(IV) pro‐drug
Miller, M. A., Zheng, Y.-R., Gadde, S., Pfirschke, C., Zope, H., Engblom, C., Kohler, R. H., Iwamoto, Y., Yang, K. S., Askevold, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms9692 · Cited by 441
Ma, J., Liu, L., Che, G., Yu, N., Dai, F., & You, Z. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-112 · Cited by 437
Agonistic CD40 Antibodies and Cancer Therapy
Vonderheide, R. H., & Glennie, M. J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2064 · Cited by 414
Puig-Kröger, A., Sierra-Filardi, E., Domínguez-Soto, A., Samaniego, R., Corcuera, M. T., Gómez-Aguado, F., Ratnam, M., Sánchez-Mateos, P., & Corbí, A. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2050 · Cited by 389
Strachan, D. C., Ruffell, B., Oei, Y., Bissell, M. J., Coussens, L. M., Pryer, N., & Daniel, D. (2013) · OncoImmunology · doi:10.4161/onci.26968 · Cited by 376
Zhang, W., Zhu, X.-D., Sun, H.-C., Xiong, Y.-Q., Zhuang, P.-Y., Xu, H.-X., Kong, L.-Q., Wang, L., Wu, W.-Z., & Tang, Z.-Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2904 · Cited by 374
Ren, G., Zhao, X., Wang, Y., Zhang, X., Chen, X., Xu, C., Yuan, Z.-R., Roberts, A. I., Zhang, L., Zheng, B., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.08.013 · Cited by 361
Clift, M. J. D., Rothen-Rutishauser, B., Brown, D. M., Duffin, R., Donaldson, K., Proudfoot, L., Guy, K., & Stone, V. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.06.009 · Cited by 358
Kloepper, J., Riedemann, L., Amoozgar, Z., Seano, G., Susek, K., Yu, V., Dalvie, N., Amelung, R. L., Datta, M., Song, J. W., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525360113 · Cited by 357
SCS macrophages suppress melanoma by restricting tumor-derived vesicle–B cell interactions
Pucci, F., Garris, C., Lai, C. P., Newton, A., Pfirschke, C., Engblom, C., Alvarez, D., Sprachman, M., Evavold, C., Magnuson, A., et al. (2016) · Science · doi:10.1126/science.aaf1328 · Cited by 349
Allen, T. M., Austin, G. A., Chonn, A., Lin, L., & Lee, K. C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90268-d · Cited by 345
Coffelt, S. B., Tal, A. O., Scholz, A., De Palma, M., Patel, S., Urbich, C., Biswas, S. K., Murdoch, C., Plate, K. H., Reiss, Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0012 · Cited by 343
TLR agonists: our best frenemy in cancer immunotherapy
Kaczanowska, S., Joseph, A. M., & Davila, E. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012501 · Cited by 339
Li, F., & Ravetch, J. V. (2011) · Science · doi:10.1126/science.1206954 · Cited by 335
Cooperation of Immune Lymphoid Cells with Macrophages in Tumour Immunity
EVANS, R., & ALEXANDER, P. (1970) · Nature · doi:10.1038/228620a0 · Cited by 333
Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake
Herd, H., Daum, N., Jones, A. T., Huwer, H., Ghandehari, H., & Lehr, C.-M. (2013) · ACS Nano · doi:10.1021/nn304439f · Cited by 326
The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
Sánchez-Martín, L., Estecha, A., Samaniego, R., Sánchez-Ramón, S., Vega, M. Á., & Sánchez-Mateos, P. (2011) · Blood · doi:10.1182/blood-2009-12-258186 · Cited by 325
Tumour macrophages as potential targets of bisphosphonates
Rogers, T. L., & Holen, I. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-177 · Cited by 324
Xia, W., Hilgenbrink, A. R., Matteson, E. L., Lockwood, M. B., Cheng, J.-X., & Low, P. S. (2009) · Blood · doi:10.1182/blood-2008-04-150789 · Cited by 318
Otero, K., Turnbull, I. R., Poliani, P. L., Vermi, W., Cerutti, E., Aoshi, T., Tassi, I., Takai, T., Stanley, S. L., Miller, M., et al. (2009) · Nature Immunology · doi:10.1038/ni.1744 · Cited by 315
Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival
Cieslewicz, M., Tang, J., Yu, J. L., Cao, H., Zavaljevski, M., Motoyama, K., Lieber, A., Raines, E. W., & Pun, S. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312197110 · Cited by 314
Self-citationOptimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells
Richards, J. O., Karki, S., Lazar, G. A., Chen, H., Dang, W., & Desjarlais, J. R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0201 · Cited by 313
Polarization dictates iron handling by inflammatory and alternatively activated macrophages
Corna, G., Campana, L., Pignatti, E., Castiglioni, A., Tagliafico, E., Bosurgi, L., Campanella, A., Brunelli, S., Manfredi, A. A., Apostoli, P., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.023879 · Cited by 304 · cited 1×
“Legumain and transferrin receptor are two other target receptors overexpressed on M2-TAMs compared to M1TAMs but that are also present on several cancer cell types [200][201][202].”
De Palma, M., Mazzieri, R., Politi, L. S., Pucci, F., Zonari, E., Sitia, G., Mazzoleni, S., Moi, D., Venneri, M. A., Indraccolo, S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.09.004 · Cited by 301
Mannose-targeted systems for the delivery of therapeutics
Irache, J. M., Salman, H. H., Gamazo, C., & Espuelas, S. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.6.703 · Cited by 293
Movahedi, K., Schoonooghe, S., Laoui, D., Houbracken, I., Waelput, W., Breckpot, K., Bouwens, L., Lahoutte, T., De Baetselier, P., Raes, G., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2994 · Cited by 291
Allavena, P., Signorelli, M., Chieppa, M., Erba, E., Bianchi, G., Marchesi, F., Olimpio, C. O., Bonardi, C., Garbi, A., Lissoni, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4037 · Cited by 286
Macrophages and Systemic Iron Homeostasis
Ganz, T. (2012) · Journal of Innate Immunity · doi:10.1159/000336423 · Cited by 281 · cited 2×
“Kupffer cells in the liver clear foreign, pathogenic, and waste materials from circulation [11].”
Clark, A. J., & Davis, M. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517048112 · Cited by 280
Anti‐tumour strategies aiming to target tumour‐associated macrophages
Tang, X., Mo, C., Wang, Y., Wei, D., & Xiao, H. (2013) · Immunology · doi:10.1111/imm.12023 · Cited by 278
Malyshev, I., & Malyshev, Y. (2015) · BioMed Research International · doi:10.1155/2015/341308 · Cited by 276
Coscia, M., Quaglino, E., Iezzi, M., Curcio, C., Pantaleoni, F., Riganti, C., Holen, I., Mönkkönen, H., Boccadoro, M., Forni, G., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00926.x · Cited by 275
Long, K. B., Gladney, W. L., Tooker, G. M., Graham, K., Fraietta, J. A., & Beatty, G. L. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1032 · Cited by 275
Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation
Ruan, S., Hu, C., Tang, X., Cun, X., Xiao, W., Shi, K., He, Q., & Gao, H. (2016) · ACS Nano · doi:10.1021/acsnano.6b05070 · Cited by 263
Bartneck, M., Keul, H. A., Singh, S., Czaja, K., Bornemann, J., Bockstaller, M., Moeller, M., Zwadlo-Klarwasser, G., & Groll, J. (2010) · ACS Nano · doi:10.1021/nn100262h · Cited by 253
Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery
Dou, H., Destache, C. J., Morehead, J. R., Mosley, R. L., Boska, M. D., Kingsley, J., Gorantla, S., Poluektova, L., Nelson, J. A., Chaubal, M., et al. (2006) · Blood · doi:10.1182/blood-2006-03-012534 · Cited by 253
The Multifaceted Role of Perivascular Macrophages in Tumors
Lewis, C. E., Harney, A. S., & Pollard, J. W. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.017 · Cited by 249
Tyrosine kinase inhibitors: Multi-targeted or single-targeted?
Broekman, F. (2011) · World Journal of Clinical Oncology · doi:10.5306/wjco.v2.i2.80 · Cited by 247
Dou, H., Grotepas, C. B., McMillan, J. M., Destache, C. J., Chaubal, M., Werling, J., Kipp, J., Rabinow, B., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900274 · Cited by 237
Zhu, S., Niu, M., O’Mary, H., & Cui, Z. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400216r · Cited by 232
Phenotype Determines Nanoparticle Uptake by Human Macrophages from Liver and Blood
MacParland, S. A., Tsoi, K. M., Ouyang, B., Ma, X.-Z., Manuel, J., Fawaz, A., Ostrowski, M. A., Alman, B. A., Zilman, A., Chan, W. C. W., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06245 · Cited by 229
Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
White, A. L., Chan, H. T. C., Roghanian, A., French, R. R., Mockridge, C. I., Tutt, A. L., Dixon, S. V., Ajona, D., Verbeek, J. S., Al-Shamkhani, A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101135 · Cited by 226
Glomerular Mesangial Cells: Electrophysiology and Regulation of Contraction
STOCKAND, J. D., & SANSOM, S. C. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.3.723 · Cited by 225
M1/M2 Macrophage Polarity in Normal and Complicated Pregnancy
Brown, M. B., von Chamier, M., Allam, A. B., & Reyes, L. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00606 · Cited by 224
Use of macrophages to deliver therapeutic and imaging contrast agents to tumors
Choi, J., Kim, H.-Y., Ju, E. J., Jung, J., Park, J., Chung, H.-K., Lee, J. S., Lee, J. S., Park, H. J., Song, S. Y., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.022 · Cited by 215
Yuan, Z.-Y., Luo, R.-Z., Peng, R.-J., Wang, S.-S., & Xue, C. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s61838 · Cited by 214
Gül, N., & van Egmond, M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1330 · Cited by 210
Macrophage-based cell therapies: The long and winding road
Lee, S., Kivimäe, S., Dolor, A., & Szoka, F. C. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.018 · Cited by 198
Mei, J., Xiao, Z., Guo, C., Pu, Q., Ma, L., Liu, C., Lin, F., Liao, H., You, Z., & Liu, L. (2016) · Oncotarget · doi:10.18632/oncotarget.9079 · Cited by 196
Shi, Y., Fan, X., Deng, H., Brezski, R. J., Rycyzyn, M., Jordan, R. E., Strohl, W. R., Zou, Q., Zhang, N., & An, Z. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402891 · Cited by 195
Key, J., Palange, A. L., Gentile, F., Aryal, S., Stigliano, C., Di Mascolo, D., De Rosa, E., Cho, M., Lee, Y., Singh, J., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b04866 · Cited by 190
Nakanishi, Y., Nakatsuji, M., Seno, H., Ishizu, S., Akitake-Kawano, R., Kanda, K., Ueo, T., Komekado, H., Kawada, M., Minami, M., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr128 · Cited by 190
Chono, S., Tanino, T., Seki, T., & Morimoto, K. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.1.0010 · Cited by 190
Macrophage-Induced Tumor Angiogenesis Is Regulated by the TSC2–mTOR Pathway
Chen, W., Ma, T., Shen, X.-N., Xia, X.-F., Xu, G.-D., Bai, X.-L., & Liang, T.-B. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2684 · Cited by 189
Hybrid-Actuating Macrophage-Based Microrobots for Active Cancer Therapy
Han, J., Zhen, J., Nguyen, V. D., Go, G., Choi, Y., Ko, S. Y., Park, J.-O., & Park, S. (2016) · Scientific Reports · doi:10.1038/srep28717 · Cited by 188
Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment
Liu, Z., Xiong, M., Gong, J., Zhang, Y., Bai, N., Luo, Y., Li, L., Wei, Y., Liu, Y., Tan, X., et al. (2014) · Nature Communications · doi:10.1038/ncomms5280 · Cited by 185
Baghdadi, M., Wada, H., Nakanishi, S., Abe, H., Han, N., Putra, W. E., Endo, D., Watari, H., Sakuragi, N., Hida, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1170 · Cited by 180
Gu, L., Li, H., Chen, L., Ma, X., Li, X., Gao, Y., Zhang, Y., Xie, Y., & Zhang, X. (2016) · Oncotarget · doi:10.18632/oncotarget.7876 · Cited by 178
Alternative activation of tumor-associated macrophages by IL-4: Priming for protumoral functions
Wang, H.-W., & Joyce, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.24.14322 · Cited by 177
Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages
Yu, S., Lau, Thomas, Jerome, Dickerson, Giorgio, T., Hubbell, & Maron (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28531 · Cited by 171
Shape Effect of Glyco-Nanoparticles on Macrophage Cellular Uptake and Immune Response
Li, Z., Sun, L., Zhang, Y., Dove, A. P., O’Reilly, R. K., & Chen, G. (2016) · ACS Macro Letters · doi:10.1021/acsmacrolett.6b00419 · Cited by 165
Size-Dependent Attenuation of TLR9 Signaling by Gold Nanoparticles in Macrophages
Tsai, C.-Y., Lu, S.-L., Hu, C.-W., Yeh, C., Lee, G., & Lei, H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100344 · Cited by 163
Sahin, E., Haubenwallner, S., Kuttke, M., Kollmann, I., Halfmann, A., Dohnal, A. M., Chen, L., Cheng, P. P., Hoesel, B., Einwallner, E., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302167 · Cited by 163
Torti, S. V., & Torti, F. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3614 · Cited by 158
Junankar, S. R., Shay, G., Jurczyluk, J., Ali, N., Down, J. M., POCOCK, N. A., Parker, A., Nguyen, A., Sun, S., Kashemirov, B. A., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0621 · Cited by 157
Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting
Muthana, M., Kennerley, A. J., Hughes, R., Fagnano, E., Richardson, J., Paul, M., Murdoch, C., Wright, F., Payne, C., Lythgoe, M. F., et al. (2015) · Nature Communications · doi:10.1038/ncomms9009 · Cited by 157
Ji, J., Eggert, T., Budhu, A., Forgues, M., Takai, A., Dang, H. T., Ye, Q., Lee, J., Kim, J. H., Greten, T. F., et al. (2015) · Hepatology · doi:10.1002/hep.27822 · Cited by 155
The Role of Macrophages in Utero-placental Interactions During Normal and Pathological Pregnancy
Renaud, S. J., & Graham, C. H. (2008) · Immunological Investigations · doi:10.1080/08820130802191375 · Cited by 154
Bisphosphonates for Treatment and Prevention of Bone Metastases
Michaelson, M. D., & Smith, M. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.9579 · Cited by 153
Dheilly, E., Moine, V., Broyer, L., Salgado-Pires, S., Johnson, Z., Papaioannou, A., Cons, L., Calloud, S., Majocchi, S., Nelson, R. J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.006 · Cited by 149
Jassar, A. S., Suzuki, E., Kapoor, V., Sun, J., Silverberg, M. B., Cheung, L., Burdick, M. D., Strieter, R. M., Ching, L., Kaiser, L. R., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1658 · Cited by 148
The effects of charge and size on the interaction of unilamellar liposomes with macrophages
Schwendener, R. A., Lagocki, P., & Rahman, Y. E. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90521-2 · Cited by 147
Kang, T., Jiang, M., Jiang, D., Feng, X., Yao, J., Song, Q., Chen, H., Gao, X., & Chen, J. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00222 · Cited by 144
Regulation of Macrophage Arginase Expression and Tumor Growth by the Ron Receptor Tyrosine Kinase
Sharda, D. R., Yu, S., Ray, M., Squadrito, M. L., Palma, M. D., Wynn, T. A., Morris, S. M., & Hankey, P. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003460 · Cited by 144
Ikehara, Y., Niwa, T., Biao, L., Ikehara, S. K., Ohashi, N., Kobayashi, T., Shimizu, Y., Kojima, N., & Nakanishi, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0470 · Cited by 143
Gebremeskel, S., & Johnston, B. (2015) · Oncotarget · doi:10.18632/oncotarget.6113 · Cited by 139
Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies
Quail, D. F., & Joyce, J. A. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0133 · Cited by 137
Nagai, T., Tanaka, M., Tsuneyoshi, Y., Xu, B., Michie, S. A., Hasui, K., Hirano, H., Arita, K., & Matsuyama, T. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0667-x · Cited by 134
Ohnishi, K., Komohara, Y., Saito, Y., Miyamoto, Y., Watanabe, M., Baba, H., & Takeya, M. (2013) · Cancer Science · doi:10.1111/cas.12212 · Cited by 133
Wu, W., Luo, Y., Sun, C., Liu, Y., Kuo, P. L., Varga, J., Xiang, R., Reisfeld, R. A., Janda, K. D., Edgington, T. S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2591 · Cited by 131
Yu, X., Guo, C., Fisher, P. B., Subjeck, J. R., & Wang, X. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.04.004 · Cited by 124
Macrophages as Cell-Based Delivery Systems for Nanoshells in Photothermal Therapy
Madsen, S. J., Baek, S., Makkouk, A., Krasieva, T. B., & Hirschberg, H. (2011) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0415-1 · Cited by 123
Neyen, C. D., Plüddemann, A., Mukhopadhyay, S., Maniati, E., Bossard, M., Gordon, S., & Hagemann, T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203194 · Cited by 121
Paclitaxel Enhances Macrophage IL-12 Production in Tumor-Bearing Hosts Through Nitric Oxide
Mullins, D. W., Burger, C. J., & Elgert, K. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6811 · Cited by 117
Tumor-Associated Macrophages Promote Invasion while Retaining Fc-Dependent Anti-Tumor Function
Grugan, K. D., McCabe, F. L., Kinder, M., Greenplate, A. R., Harman, B. C., Ekert, J. E., van Rooijen, N., Anderson, G. M., Nemeth, J. A., Strohl, W. R., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201889 · Cited by 116
Wang, S., Yu, C., Hong, J., Tsai, C.-S., & Chiang, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069182 · Cited by 115
Bruns, H., Büttner, M., Fabri, M., Mougiakakos, D., Bittenbring, J. T., Hoffmann, M. H., Beier, F., Pasemann, S., Jitschin, R., Hofmann, A. D., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3230 · Cited by 107
Macrophages: Gatekeepers of Tissue Integrity
Lavin, Y., & Mérad, M. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0117 · Cited by 104
A Milestone Review on How Macrophages Affect Tumor Growth
Caux, C., Ramos, R. N., Prendergast, G. C., Bendriss‐Vermare, N., & Ménétrier‐Caux, C. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-2631 · Cited by 103
Macrophage-Mediated Trogocytosis Leads to Death of Antibody-Opsonized Tumor Cells
Velmurugan, R., Challa, D. K., Ram, S., Ober, R. J., & Ward, E. S. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0335 · Cited by 100
Lohela, M. K., Casbon, A.-J., Olow, A., Bonham, L., Branstetter, D. G., Weng, N., Smith, J., & Werb, Z. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419899111 · Cited by 98
Sosale, N. G., Spinler, K. R., Alvey, C. M., & Discher, D. E. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.06.013 · Cited by 97
Liguori, M., Buracchi, C., Pasqualini, F., Bergomas, F., Pesce, S., Sironi, M., Grizzi, F., Mantovani, A., Belgiovine, C., & Allavena, P. (2016) · Oncotarget · doi:10.18632/oncotarget.9340 · Cited by 94
Guerriero, J. L., Ditsworth, D., Catanzaro, J. M., Sabino, G. J., Furie, M. B., Kew, R. R., Crawford, H. C., & Zong, W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003267 · Cited by 92
Macrophages Offer A Paradigm Switch for CNS Delivery of Therapeutic Proteins
Klyachko, N. L., Haney, M. J., Zhao, Y., Manickam, D. S., Mahajan, V., Suresh, P., Hingtgen, S. D., Mosley, R. L., Gendelman, H. E., Kabanov, A. V., et al. (2014) · Nanomedicine · doi:10.2217/nnm.13.115 · Cited by 92
Macrophage silica nanoparticle response is phenotypically dependent
Gustafson, H. H., Bartlett, K. T., Gustafson, J. A., McGill, L. D., & Ghandehari, H. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.070 · Cited by 92
Self-citationChen, Y., Fisher, J. H., & Wang, M.-H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4950 · Cited by 91
Li, F., Ulrich, M. L., Jonas, M., Stone, I. J., Linares, G., Zhang, X., Westendorf, L., Benjamin, D. R., & Law, C. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0019 · Cited by 91
Tipton, T. R. W., Roghanian, A., Oldham, R. J., Carter, M. J., Cox, K. L., Mockridge, C. I., French, R. R., Dahal, L. N., Duriez, P. J., Hargreaves, P. G., et al. (2015) · Blood · doi:10.1182/blood-2014-07-588376 · Cited by 90
Ho, C. C. M., Ring, N. G., Sockolosky, J. T., Ring, A. M., Weiskopf, K., Özkan, E., Mori, Y., Weissman, I. L., & García, K. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.648220 · Cited by 88
Jung, M., Ören, B., Mora, J., Mertens, C., Dziumbla, S., Popp, R., Weigert, A., Grossmann, N., Fleming, I., & Brüne, B. (2016) · Science Signaling · doi:10.1126/scisignal.aaf3241 · Cited by 87
Josephs, D. H., Bax, H. J., Dodev, T. S., Georgouli, M., Nakamura, M., Pellizzari, G., Saul, L., Karagiannis, P., Cheung, A., Herráiz, C., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1829 · Cited by 87
Lehmann, B., Biburger, M., Brückner, C., Ipsen-Escobedo, A., Gordan, S., Lehmann, C. H. K., Voehringer, D., Winkler, T., Schaft, N., Dudziak, D., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aah6413 · Cited by 85
Mertens, C., Akam, E. A., Rehwald, C., Brüne, B., Tomat, E., & Jung, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166164 · Cited by 83
The Multifaceted Role of Perivascular Macrophages in Tumors
Lewis, C. E., Harney, A. S., & Pollard, J. W. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.009 · Cited by 83
Tanei, T., Leonard, F., Liu, X., Alexander, J. F., Saito, Y., Mauro Ferrari, B., Godin, B., & Yokoi, K. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1576 · Cited by 78
Macrophage Susceptibility to Emactuzumab (RG7155) Treatment
Pradel, L. P., Ooi, C.-H., Romagnoli, S., Cannarile, M. A., Sade, H., Rüttinger, D., & Ries, C. H. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0157 · Cited by 77
Molecular Imaging of Tumor-Infiltrating Macrophages in a Preclinical Mouse Model of Breast Cancer
Sun, X., Gao, D., Gao, L., Zhang, C., Yu, X., Jia, B., Wang, F., & Liu, Z. (2015) · Theranostics · doi:10.7150/thno.11546 · Cited by 74
Morrison, A. C., Wilson, C. B., Ray, M., & Correll, P. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1825 · Cited by 73
Selective ablation of tumor‐associated macrophages suppresses metastasis and angiogenesis
Lin, Y., Wei, C., Liu, Y., Qiu, Y., Liu, C., & Guo, F. (2013) · Cancer Science · doi:10.1111/cas.12202 · Cited by 73
Eyob, H., Ekiz, H. A., DeRose, Y. S., Waltz, S. E., Williams, M. A., & Welm, A. L. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0480 · Cited by 73
The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer
Shiota, T., Miyasato, Y., Ohnishi, K., Yamamoto‐Ibusuki, M., Yamamoto, Y., Iwase, H., Takeya, M., & Komohara, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166680 · Cited by 72
Ngambenjawong, C., Cieslewicz, M., Schellinger, J. G., & Pun, S. H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.057 · Cited by 69
Self-citationDasatinib is a potent inhibitor of tumour-associated macrophages, osteoclasts and the FMS receptor
Brownlow, N., Mol, C. D., Hayford, C., Ghaem‐Maghami, S., & Dibb, N. J. (2008) · Leukemia · doi:10.1038/leu.2008.237 · Cited by 68
Polyelectrolyte Complex Optimization for Macrophage Delivery of Redox Enzyme Nanoparticles
Zhao, Y., Haney, M. J., Klyachko, N. L., Li, S., Booth, S. L., Higginbotham, S. M., Jones, J., Zimmerman, M. C., Mosley, R. L., Kabanov, A. V., et al. (2010) · Nanomedicine · doi:10.2217/nnm.10.129 · Cited by 64
Macrophage PPARγ inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone
Cheng, W. Y., Huynh, H., Chen, P., Peña‐Llopis, S., & Wan, Y. (2016) · eLife · doi:10.7554/elife.18501 · Cited by 64
Cited by
Immunotherapy in colorectal cancer: Rationale, challenges and potential
Ganesh, K., Stadler, Z. K., Cercek, A., Mendelsohn, R. B., Shia, J., Segal, N. H., & Diaz, L. A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0126-x · Cited by 1,954
Tumor-Associated Macrophages in Tumor Immunity
Pan, Y., Yu, Y., Wang, X., & Zhang, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583084 · Cited by 1,872
Tumor-associated macrophages: an accomplice in solid tumor progression
Chen, Y., Song, Y., Du, W., Gong, L., Chang, H., & Zou, Z. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0568-z · Cited by 1,096
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
Yang, M., Li, J., Gu, P., & Fan, X. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.010 · Cited by 670
Metadata
- Authors
- Ngambenjawong, C., Gustafson, H. H., & Pun, S. H.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 114
- Pages
- 206-221
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2609512644
- Cited by
- 840
- References
- 223
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.